Monte Rosa Therapeutics (GLUE) Non-cash Items (2020 - 2026)

Monte Rosa Therapeutics' Non-cash Items history runs 7 years deep, the most recent figure standing at $122.6 million for Q1 2026.

• In Q1 2026, Non-cash Items rose 1539.96% year-over-year to $122.6 million; the TTM figure through Mar 2026 stood at $122.6 million (up 1539.96% YoY), while the FY2025 annual figure was $8.1 million, down 29.25% from the prior year.
• Non-cash Items was $122.6 million for Q1 2026 at Monte Rosa Therapeutics, up from $115.2 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $122.6 million in Q1 2026 to a low of $1.7 million in Q2 2022.
• Historically, Non-cash Items has averaged $22.0 million across 5 years, with a median of $8.1 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Non-cash Items jumped 4523.23% in 2022, then tumbled 92.31% in 2023.
• A 5-year view of Non-cash Items shows it stood at $12.4 million in 2022, then tumbled by 61.89% to $4.7 million in 2023, then soared by 140.86% to $11.4 million in 2024, then jumped by 909.24% to $115.2 million in 2025, then climbed by 6.42% to $122.6 million in 2026.
• The last three Non-cash Items figures came in at $122.6 million (Q1 2026), $115.2 million (Q4 2025), and $8.5 million (Q3 2025), per Business Quant data.